Димитрова, Н. Епидемиология на кожен меланом - къде е България под слънцето на Европа.- В: Учебна книга 2015. Клинич- но поведение при кожен меланом, включително базоцелуларен, плоскоклетъчен и Merkel-клетъчен кожен карцином и текстове за продължаващо медицинско обучение. Под ред. Д. Калев. Варна, Арт Трейсър, 2015, 13-20.
Заболяемост от рак в България, 2013. Том 24. София, Национална болница по онко- логия, 2015.
Чернев, Г., А. Чокоева. Малигнен меланом. София, Университетско издателство „Св. Климент Охридски“, 2015. 200 с.
Arnold M., E. Rentería, D. I. Conway, F. Bray, T. Van Ourti, I. Soerjomataram. Inequalities in cancer incidence and mortality across medium to highly developed countries in the twenty-first century.- Cancer Causes Control. 2016;27(8):999-1007.
Baldwin J., A. E. Janitz, J. Erb-Alvarez, C. Snider, J. E. Campbell. Prevalence and mortality of melanoma in Oklahoma among racial groups, 2000-2008.- J Okla State Med Assoc. 2016;109(7-8):311-316.
Barbaric J., M. Sekerija, D. Agius, D. Coza, N. Dimitrova, A. Demetriou, et al. Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner?- Eur J Cancer. 2016;55:47-55.
Chen L., S. Jin. Trends in mortality rates of cutaneous melanoma in East Asian populations.- PeerJ. 2016;4:e2809. doi: 10.7717/peerj.2809.
Chi Z., S. Li, X. Sheng, L. Si, C. Cui, M. Han, et al. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases.- BMC Cancer. 2011;25(11):85.
Cokkinides V. E., A. C. Geller, A. Jemal. Trends in melanoma mortality among non-Hispanic whites by educational attainment, 1993-2007.- Arch Dermatol. 2012;148(5):587-591.
Cossu A., M. Casula, R. Cesaraccio, A. Lissia, M. Colombino, M. C. Sini, et al. Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy.- Eur J Cancer Prev. 2016 Mar 18. doi: 10.1097/CEJ.0000000000000223.
Ferlay J., I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers, et al. GLOBOCAN 2012 v1.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, International Agency for Research on Cancer, 2013.
Ferlay J., I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012.- Int J Cancer 2015;136(5):E359-E386.
Garnett E., J. Townsend, B. Steele, M. Watson. Characteristics, rates, and trends of melanoma incidence among Hispanics in the USA.- Cancer Causes Control. 2016;27(5):647-659.
Johnson-Obaseki S. E., V. Labajian, M. J. Corsten, J. T. McDonald. Incidence of cutaneous malignant melanoma by socioeconomic status in Canada: 1992-2006.- J Otolaryngol Head Neck Surg. 2015;44:53. doi: 10.1186/s40463-015-0107-1.
Kolk A., K. D. Wolff, R. Smeets, M. Kesting, R. Hein, A. W. Eckert. Melanotic and nonmelanotic malignancies of the face and external ear - A review of current treatment concepts and future options.- Cancer Treat Rev. 2014;40(7):819-837.
Lazar A. J., G. F. Murphy. Melanoma.- In: Robbins and Cotran Pathologic basis of disease. 9th ed. V. Kumar, A. K. Abbas, J. C. Aster, eds. Philadelphia, Elsevier Saunders, 2015, 1147-1150.
Monshi B., M. Vujic, D. Kivaranovic, A. Sesti, W. Oberaigner, I. Vujic, et al. The burden of malignant melanoma - Lessons to be learned from Austria.- Eur J Cancer. 2016:56:45-53.
Olazagasti Lourido J. M., J. E. Ma, C. M. Lohse, J. D. Brewer. Increasing incidence of мelanoma in the еlderly: аn еpidemiological сtudy in Olmsted County, Minnesota.- Mayo Clin Proc. 2016;91(11):1555-1562.
Schoffer O., Schülein S, Arand G, Arnholdt H, Baaske D, Bargou RC, et al. Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011.- BMC Cancer. 2016;16(1):936.
Shellenberger R., M. Nabhan, S. Kakaraparthi. Melanoma screening: A plan for improving early detection.- Ann Med. 2016;48(3):142-148.
Shen W., N. Sakamoto, L. Yang. Melanomaspecific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.- BMC Cancer. 2016;16:413.
Steliarova-Foucher E., M. O’Callaghan, J. Ferlay, E. Masuyer, S. Rosso, D. Forman, et al. The European Cancer Observatory: A new data resource.- Eur J Cancer. 2015;51(9):1131-1143.
Strömberg U., S. Peterson, E. Holmberg, A. Holmén, B. Persson, C. Sandberg, et al. Cutaneous malignant melanoma show geographic and socioeconomic disparities in stage at diagnosis and excess mortality.- Acta Oncol. 2016;55(8):993-1000.
Tellez A., S. Rueda, R. Z. Conic, K. Powers, I. Galdyn, N. A. Mesinkovska, et al. Risk factors and outcomes of cutaneous melanoma in women less than 50 years of age. J Am Acad Dermatol. 2016;74(4):731-738.
Trautmann F., F. Meier, A. Seidler, J. Schmitt. Effects of the German skin cancer screening program on melanoma incidence and indicators of disease severity.- Br J Dermatol. 2016;175(5):912-919.
Wang Y., Y. Zhao, S. Ma. Racial differences in six major subtypes of melanoma: descriptive epidemiology.- BMC Cancer. 2016;16:691.
Znaor A, C. van den Hurk, M. Primic- Zakelj, D. Agius, D. Coza, A. Demetriou, N. Dimitrova, et al. Cancer incidence and mortality patterns in South Eastern Europe in the last decade: Gaps persist compared with the rest of Europe. Eur J Cancer. 2013;49(7):1683-1691.
